Faraday Pharmaceuticals

Closed

Seattle, United States · Founded 2016 · $99.2M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$99.2M
Last Round
$52.8M Series BNov 2022
Rounds
5

About

Faraday Pharmaceuticals is a clinical-stage biopharmaceutical company founded by Dr. Mark Roth of the Fred Hutchinson Cancer Center. The company pioneered the use of elemental reducing agents to protect against muscle loss in cardiac and critical care settings. As of 2025, the company has ceased operations and is winding down.

Summary

Faraday Pharmaceuticals is a Biotech company based in Seattle, United States, founded in 2016. It has raised $99.2M in total across 5 rounds, most recently a $52.8M Series B round in Nov 2022. Investors include ARCH Venture Partners, Polaris Partners and Osage University Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BNov 2022
$52.8M

Sign up to see all 5 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Faraday Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/faraday-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/faraday-pharmaceuticals" alt="Faraday Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>